← All trials
NCT05204862
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 2, 2021
- Primary completion
- Jun 30, 2026
- Completion date
- Sep 30, 2027
- First posted
- Jan 24, 2022
- Last posted
- Apr 3, 2023
- Enrollment
- 240
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- TiumBio Co., Ltd.Lead sponsor
- TiumBio Co., Ltd.Official
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.